Clinical Trial Update: 68Ga PSMA in Preprostatectomy Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating 68Ga PSMA in preprostatectomy patients for prostate cancer; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA

Snippet

Sponsor: Michael Graham PhD, MD | Conditions: Prostate Cancer, Prostatic Neoplasm | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-02-15